Nicotine Dependence-Induced Withdrawal Syndrome: Mechanistic Insights and Therapeutic Implications

View at publisher
Authors: Heena Khan, Annu Bangar, Aastha Sharma, Amarjot Kaur, Takveer Singh
Cited by: 1

Abstract

Tobacco consumption is a worldwide issue that has significant health repercussions. Each year, related diseases result in an expenditure of billions of dollars in healthcare costs and diminished productivity. People are becoming more conscious of the fact that quitting smoking at any age can prolong life and lessen many of the negative consequences of smoking. While there are currently some treatment options available, there is still a substantial demand for novel and efficient pharmacotherapies to assist smokers in achieving and sustaining long-term sobriety. The symptoms of nicotine withdrawal are a significant obstacle to cessation and must be alleviated to prevent early recurrence. This article has discussed the neurotransmitters that are responsible for nicotine reward and the anatomical structures implicated in nicotine withdrawal. A simple hypothesis regarding tobacco addiction posits that nicotine is the primary addictive constituent of tobacco. Anxiety, depression, and stress have intricate effects on every facet of nicotine dependency, including the withdrawal experience. Smokers commonly utilize smoking as a means to reduce tension and anxiety, as it is believed to have a relaxing effect. This increasing knowledge offers a detailed understanding of the mechanisms behind existing and future smoking cessation treatments. Therefore, nicotine withdrawal is a significant factor influencing continued nicotine product use and contributes to unsuccessful cessation attempts. In conclusion, nicotine withdrawal may lead to cognitive changes and attention disturbances in the short term and enhance exercise-related physical abilities in the long term.

Fields of Study & Subjects

Smoking Behavior and Cessation Nicotinic Acetylcholine Receptors Study Neurotransmitter Receptor Influence on Behavior

Publication details

Journal / source
CNS & Neurological Disorders - Drug Targets
Publisher
Bentham Science Publishers Ltd.
Volume
25
Publication date
16 January 2026
Language
EN